Recent Posts

FDA Grants Breakthrough Therapy Designation to Orphazyme’s Arimoclomol for Treatment of Niemann-Pick Disease Type C

Copenhagen, Denmark, November 19, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with …

Read More »

Vertex and Molecular Templates Collaborate to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

BOSTON and AUSTIN, Texas, Nov. 18, 2019 (GLOBE NEWSWIRE) — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) …

Read More »